1. Alman BA, Greel DA, Wolfe HJ. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res. 1996;14(2):311-315.
2. DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848-1864.
3. Wei-Jen Chen, Wei-Ming Chen, Chao-Ching Chiang, Ching-Kuei Huang, Tain-Hsiung Chen, Wai-Hee Lo. J Chin Med Assoc. 2005;68(7):343-346.
4. Albright F, Butler AM, Hampton A, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216:727-746.
5. Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35(1):235-242.
6. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet.1994;16:343(8903):953-954.
7.Bernando Vagars. Orthopaedic surgery for Fibrous Dysplasia emedicine. Medscape. 2016.
8. Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur. Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am. 1998; 80(5):648-658.
9. Lee SE, Lee EH, Park H, et al. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.Hum Pathol. 2012;43(8):1234-1242.
10. DiCaprio MR and Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848-1864.
11. Russell LW, Chandler FA. Fibrous dysplasia of bone. J Bone Joint Surg Am. 1950;32(2):323-337.
12. Enneking WF, Grearen PF. Fibrous dysplasia of the femoral neck. Treatment by cortical bone-grafting. J Bone Joint Surg Am. 1986;68(9):1415-1422.
13. Lane JM, Khan SN, O'Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;382:6-12.
14. Chapurlat RD, Delmas PD, Liens D Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997;12(10):1746-1752.
15. Ozaki T, Sugihara M, Nakatsuka Y, Kawai A, Inoue H. Polyostotic fibrous dysplasia: a long term follow up of 8 patients. Int Orthop. 1996;20(4):227-232.
16. Breck LW. Treatment of fibrous dysplasia of bone by total femoral plating and hip nailing. Clin Orthop. 1972;(82):82-83.
17. Connolly JF. Shepherd's crook deformity of polyostotic fibrous dysplasia treated by osteotomy and Zickel nail fixation. Clin Orthop Relat Res. 1977;(123):22-24.
18. Freeman BH, Bray EW 3rd, Meyer LC. Multiple osteotomies with Zickel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur. J Bone Joint Surg [Am] 1987;69(5):691-698.
19. Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur: long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg [Am] 1998;80(5):648-658.
20. Yamamoto T, Hashimoto Y, Mizuno K. Oblique wedge osteotomy for femoral diaphyseal deformity in fibrous dysplasia.Clin Orthop. 2001;384:245-249.
21. Enneking WF. Fibrous lesion originating in bone. In Musculoskeletal Tumor Surgery. New York: Churchill- Livingstone. 1983;855-867.
22. Campanacci M. Fibrous dysplasia in Bone and Soft Tissue Tumors, 2nd edition. New York: Springer-Verlag Wien. 1999:435-461.